State Tobacco Monopoly Administration Releases Typical Cases of E-Cigarette Law Enforcement

Nov.07.2024
State Tobacco Monopoly Administration Releases Typical Cases of E-Cigarette Law Enforcement
The State Tobacco Monopoly Administration has strengthened e-cigarette regulation by releasing three typical cases to intensify the crackdown on illegal activities within the industry.

2Firsts Reprinted and Translated from the State Tobacco Monopoly Administration

 

This year, tobacco monopoly administrative departments at all levels have resolutely implemented the decisions and directives of the Central Committee of the Communist Party and the State Council, strengthening the full-chain regulation of e-cigarettes.

 

They have taken strong action against illegal and non-compliant e-cigarette activities, investigating and addressing administrative cases in accordance with the law, while continuously working to purify the market order and environment for e-cigarettes. To maximize their deterrent effect, the State Tobacco Monopoly Administration has released three typical cases of e-cigarette law enforcement.

 

 

Zhejiang Mirui Sales of Illegally Manufactured E-Cigarette Products

 

 

From January 2024 until the case was discovered, Zhejiang Mirui Electronic Technology Co., Ltd. (e-cigarette brand holder, tobacco monopoly manufacturing license number: 7133020055, hereinafter referred to as Zhejiang Mirui) repeatedly instructed Shenzhen Langyou Biotechnology Co., Ltd. (a vaporizer production company, tobacco monopoly manufacturing license number: 4144030089, hereinafter referred to as Shenzhen Langyou) to add ingredients to domestic e-cigarette products, such as the "MR Miroo - Meteor Disposable E-Cigarette (Wu Ti)," that were not included in the technically reviewed formula.

 

This resulted in discrepancies between the actual products and the information approved through the technical review, constituting the sale of illegally produced e-cigarette products. In accordance with relevant laws and regulations, Zhejiang Mirui was ordered to cease selling the products, confiscate the illegal gains, and pay a fine of 1.0012 million yuan. Shenzhen Langyou has been dealt with in a separate case.

 

 

Shenzhen Bode Sales of Illegally Manufactured E-Cigarette Products, Operating Outside the Permitted Scope of Vaporizer Production

 

 

From January 2024 until the case was discovered, Boulder (Shenzhen) Technologies, Inc. (e-cigarette brand holder, tobacco monopoly manufacturing license number: 7144030063, hereinafter referred to as Shenzhen Boulder) added ingredients to domestic e-cigarette products like the "Bode Boulder - Classic Series - Jade Dragon Snow Mountain" that were not included in the technically reviewed formula. This led to discrepancies between the products and the approved technical review information, constituting the sale of illegally produced e-cigarette products. 

 

Additionally, Shenzhen Boulder did not possess the qualification to produce vaporizers and, from October 2022 to May 2024, it produced and exported vaporizers, thus engaging in business activities outside its permitted scope. In accordance with relevant laws and regulations, Shenzhen Boulder was ordered to stop selling the related e-cigarette products, fined 3.1514 million yuan, publicly destroyed the illegally sold e-cigarette products, suspended production and business activities for two months, and underwent business rectification.

 

 

Shenzhen Mevol Sales of Illegally Manufactured E-Cigarette Products

 

 

From November 2023 to February 2024, Shenzhen Mevol Chuangxin Technology Co. (e-cigarette brand holder, tobacco monopoly manufacturing license number: 7144030126, hereinafter referred to as Shenzhen Mevol) knowingly sold e-cigarette products such as the "Miwo Mevol-Go·Sangyu Muyu," despite discrepancies between the products and those approved through technical review. 

 

This constitutes the sale of illegally manufactured e-cigarette products. In accordance with relevant laws and regulations, Shenzhen Mevol was ordered to stop selling the related e-cigarette products, fined 805,200 yuan, and publicly destroyed the illegally sold products.

 

 

Case Warnings

 

 

In order to prevent the inducement of minors to use e-cigarettes and to safeguard public health and safety, the "E-Cigarette Management Measures" explicitly stipulate that e-cigarette products not approved through technical review must not be marketed or sold. Products available on the market must align with the information of those that have passed the technical review.

 

The companies involved in these cases, motivated by profit, have violated national laws, regulations, and regulatory provisions by introducing ingredients outside the approved technical formulas into domestic e-cigarette products. As a result, these products did not conform to the approved specifications.、

 

Such actions pose a significant risk to public health, particularly the health of minors, disrupt the integrity of the e-cigarette market, and necessitate legal investigation and appropriate penalties. The typical cases published in this instance underscore the steadfast commitment of the tobacco monopoly administrative authorities to enforce e-cigarette regulation in strict accordance with the law.

 

Moving forward, tobacco monopoly administrative departments at all levels will diligently fulfill their responsibilities in e-cigarette regulation, intensify oversight, and actively investigate similar cases. They will further strengthen legal protections against the harmful effects of e-cigarettes on minors, safeguard public health, and expedite the establishment of a robust quality assurance system for e-cigarette products.

 

The responsibility for product quality will be firmly placed on the producers of e-cigarettes, with stringent supervision over the establishment and implementation of internal quality control management systems. Additionally, efforts will be made to enhance legal education and policy dissemination, guiding e-cigarette operators to comply with laws and regulations. In doing so, the regulatory framework governing e-cigarettes will continue to be strengthened, ensuring the ongoing consolidation of legal and regulatory achievements in e-cigarette governance.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia’s Department of Home Affairs has hired Deloitte to provide data analytics, business-process, communications and project-delivery support to the Office of the Illicit Tobacco and E-Cigarette Commissioner. The government says Deloitte personnel do not provide policy advice to the Commissioner or the Australian government, with policy development and decision-making remaining with public officials. The arrangement has nevertheless drawn scrutiny because Deloitte has previously provided professional services to several tobacco and vaping companies.
Sep.03
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang Industrial Co., Ltd. has filed a patent application for an oral nicotine delivery product designed to let users actively adjust nicotine release. The product embeds two types of nicotine reservoirs with different wall thicknesses and positions inside a deformable matrix. Pressure applied with the tongue or lips can rupture the reservoirs and accelerate nicotine release. In simulated oral tests, several patent examples showed sharply higher peak nicotine release rates as applied force increased from 0 N to 1 N and 3 N. The filing explores a shift from preset release profiles toward user-triggered nicotine delivery.
Sep.01
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus distributor H&S said the zero-nicotine, zero-tar NEO vaping line will begin rolling out across FamilyMart stores in Japan from September 14, 2026, excluding some locations. The DASH line will also be sold at selected FamilyMart stores in southern Kyushu and Okinawa. Snowplus simultaneously named Japanese rock band Kishidan as a brand ambassador, combining convenience-store distribution with a broader consumer marketing push in Japan.
Sep.15